Clinical factors of T2DM patients (n = 289)
| Clinical factors | Number | % |
|---|---|---|
| Duration of diabetes (yrs) | ||
| 1 | 53 | 18.3 |
| 2–6 | 114 | 39.5 |
| ≥6 | 122 | 42.2 |
| Mean ± SD = 6.8 ± 6.5, Range = 1–39 | ||
| Complication statusa | ||
| No | 185 | 64.0 |
| Peripheral neuropathy | 64 | 22.2 |
| Nephropathy | 30 | 10.4 |
| Cardiovascular disease | 23 | 8.0 |
| Retinopathy | 14 | 4.8 |
| Diabetes foot | 5 | 1.7 |
| Peripheral vascular disease | 1 | 0.4 |
| Glycemic control (HbA1c level, %) | ||
| Controlled (≤7) | 85 | 29.4 |
| Uncontrolled (>7) | 204 | 70.6 |
| Comorbiditiesa | ||
| No | 61 | 21.1 |
| Hypertension | 178 | 61.6 |
| Hyperlipidemia | 122 | 42.2 |
| Cardiovascular disease | 15 | 5.2 |
| Others | 50 | 17.3 |
| Medications | ||
| Oral medication (one drug) | 48 | 16.6 |
| Oral medication (two drugs combination) | 130 | 45.0 |
| Oral medication (three drugs combination) | 95 | 32.9 |
| Combination of oral and injection therapy | 16 | 5.5 |
| Clinical factors | Number | % |
|---|---|---|
| 1 | 53 | 18.3 |
| 2–6 | 114 | 39.5 |
| ≥6 | 122 | 42.2 |
| Mean ± SD = 6.8 ± 6.5, Range = 1–39 | ||
| No | 185 | 64.0 |
| Peripheral neuropathy | 64 | 22.2 |
| Nephropathy | 30 | 10.4 |
| Cardiovascular disease | 23 | 8.0 |
| Retinopathy | 14 | 4.8 |
| Diabetes foot | 5 | 1.7 |
| Peripheral vascular disease | 1 | 0.4 |
| Controlled (≤7) | 85 | 29.4 |
| Uncontrolled (>7) | 204 | 70.6 |
| No | 61 | 21.1 |
| Hypertension | 178 | 61.6 |
| Hyperlipidemia | 122 | 42.2 |
| Cardiovascular disease | 15 | 5.2 |
| Others | 50 | 17.3 |
| Oral medication (one drug) | 48 | 16.6 |
| Oral medication (two drugs combination) | 130 | 45.0 |
| Oral medication (three drugs combination) | 95 | 32.9 |
| Combination of oral and injection therapy | 16 | 5.5 |
Note(s): aMultiple responses were allowed